India’s Sun Pharmaceutical Industries Ltd Unit Gets Warning from US FDA

August 31, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

MUMBAI Aug 31 (Reuters) - The U.S. unit of Indian drugmaker Sun Pharmaceutical (SUN.BO) has received a warning letter from the United States Food and Drug Administration (USFDA) after its New Jersey manufacturing plant was inspected.

Twitter
LinkedIn
Facebook
Email
Print

Regulatory Asia

Food and Drug Administration (FDA)